His239Arg SNP of HRAD9 is associated with lung adenocarcinoma

Cancer

Volumn 106, Issue 5, 2006, Pages 1117-1122

  Maniwa, Yoshimasa ^a   Yoshimura, Masahiro ^a   Bermudez, Vladimir P ^b   Okada, Kenji ^a   Kanomata, Maoki ^c   Ohbayashi, Chiho ^c   Nishimura, Yoshihiro ^a   Hayashi, Yoshitake ^a   Hurwitz, Jerard ^b   Okita, Yutaka ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Cell cycle control; DNA damage check point pathway; Nonsmall cell lung carcinoma; Nonsynonymous single nucleotide polymorphism; Rad9

Indexed keywords

ARGININE; HISTIDINE; PROTEIN RAD9;

ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HRAD9 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; DNA MUTATIONAL ANALYSIS; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33644511711     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21705     Document Type: Article

References (27)

1. Lieberman HB, Hopkins KM, Nass M, Demetrick D, Davey S. A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene. Proc Natl Acad Sci U S A. 1996;93:13890-13895.
2. Burtelow MA, Roos Mattjus PM, Rauen M, Babendure JR, Karnitz LM. Reconstitution and molecular analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA damage responsive checkpoint complex. J Biol Chem. 2001;276:25903-25909.
3. Shiomi Y, Shinozaki A, Nakada D, et al. Clamp and clamp loader structures of the human checkpoint protein complexes, Rad9-1-1 and Rad17-RFC. Genes Cells. 2002;7:861-868.
4. Venclovas C, Thelen MP. Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes. Nucleic Acids Res. 2000;28:2481-2493.
5. Roos Mattjus P, Hopkins KM, Oestreich AJ, et al. Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling. J Biol Chem. 2003;278:24428-24437.
6. Toueille M, El-Andaloussi N, Frouin I, et al. The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair. Nucleic Acids Res. 2004;32:3316-3324.
7. Wang W, Brandt P, Rossi ML, et al. The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1. Proc Natl Acad Sci U S A. 2004;101:6762-16767.
8. Maniwa Y, Yoshimura M, Bermudez VP, et al. Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cells. Cancer. 2005;103:126-132.
9. NIEHS SNPs. NIEHS Environmental Genome Project, University of Washington, Seattle, WA (URL: http://egp.gs-.washington.edu).
10. Livingston RJ, Von Niederhausern A, Jegga AG, et al. Pattern of sequence variation across 213 environmental response genes. Genome Res. 2004;14:1821-1831.
11. Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res. 2002;30:158-162.
12. Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. J Hum Genet. 2002;47:605-610.
13. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002;12:436-446.
14. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894-3900.
15. St Onge RP, Besley BD, Park M, Casselman R, Davey S. DNA damage-dependent and -independent phosphorylation of the hRad9 checkpoint protein. J Biol Chem. 2001;276:41898-41905.
16. St Onge RP, Besley BD, Pelley JL, Davey S. A role for the phosphorylation of hRad9 in checkpoint signaling. J Biol Chem. 2003;278:26620-26628.
17. St Onge RP, Udell CM, Casselman R, Davey S. The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRADl and hHUS1. Mol Biol Cell. 1999;10:1985-1995.
18. Volkmer E, Karnitz LM. Human homologs of Schizosaccharomyces pombe rad1, hus1, and rad9 form a DNA damage-responsive protein complex. J Biol Chem. 1999;274:567-570.
19. Chen MJ, Lin YT, Lieberman HB, Chen G, Lee EY. ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J Biol Chem. 2001;276:16580-16586.
20. Hirai I, Wang HG. A role of the C-terminal region of human Rad9 (hRad9) in nuclear transport of the hRad9 checkpoint complex. J Biol Chem. 2002;277:25722-25727.
21. St Onge RP, Udell CM, Casselman R, Davey S. The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1. Mol Biol Cell. 1999;10:1985-1995.
22. Burtelow MA, Kaufmann SH, Karnitz LM. Retention of the human Rad9 checkpoint complex in extraction-resistant nuclear complexes after DNA damage. J Biol Chem. 2000;275:26343-26348.
23. Komatsu K, Miyashita T, Hang H, et al. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol. 2000;2:1-6.
24. Yoshida K, Komatsu K, Wang HG, Kufe D. c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage. Mol Cell Biol. 2002;2:3292-3300.
25. Lee MW, Hirai I, Wang HG. Caspase-3-mediated cleavage of Rad9 during apoptosis. Oncogene. 2003;22;6340-6346.
26. Liu G, Zhou W, Park S, et al. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer. 2004;101:2802-2808.
27. Sakiyama T, Kohno T, Mimaki S, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005;114:730-737.